| KOLEK, Vítězslav, Miloš PEŠEK, Yvona GRYGÁRKOVÁ, Petr ZATLOUKAL, Jana SKŘIČKOVÁ, Rostislav VYZULA, Leona KOUBKOVÁ, Jaromír ROUBEC, František SALAJKA, Dimka SIXTOVÁ, Luboš PETRUŽELKA and Miloš ŠTÍCHA. Pemetrexed in the second line chemotherapy in non-small cell lung cancer. A multicentre prospective analysis of data from clinical practise. In Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer. 2011. ISSN 1556-0864. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{946759,
author = {Kolek, Vítězslav and Pešek, Miloš and Grygárková, Yvona and Zatloukal, Petr and Skřičková, Jana and Vyzula, Rostislav and Koubková, Leona and Roubec, Jaromír and Salajka, František and Sixtová, Dimka and Petruželka, Luboš and Štícha, Miloš},
booktitle = {Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer},
keywords = {Pemetrexed; Advanced NSCLC; second line chemotherapy},
language = {eng},
title = {Pemetrexed in the second line chemotherapy in non-small cell lung cancer. A multicentre prospective analysis of data from clinical practise},
year = {2011}
}
TY - CONF
ID - 946759
AU - Kolek, Vítězslav - Pešek, Miloš - Grygárková, Yvona - Zatloukal, Petr - Skřičková, Jana - Vyzula, Rostislav - Koubková, Leona - Roubec, Jaromír - Salajka, František - Sixtová, Dimka - Petruželka, Luboš - Štícha, Miloš
PY - 2011
TI - Pemetrexed in the second line chemotherapy in non-small cell lung cancer. A multicentre prospective analysis of data from clinical practise
KW - Pemetrexed
KW - Advanced NSCLC
KW - second line chemotherapy
N2 - Non small cell lung cancer (NSCLC) is one of the most aggressive tumours with unsatisfactory prognosis and extremely high mortality. Pemetrexed became one of the standard chemotherapeutic options in advanced NSCLC. It is recommended both in the 1st line and in the 2nd line.
ER -
KOLEK, Vítězslav, Miloš PEŠEK, Yvona GRYGÁRKOVÁ, Petr ZATLOUKAL, Jana SKŘIČKOVÁ, Rostislav VYZULA, Leona KOUBKOVÁ, Jaromír ROUBEC, František SALAJKA, Dimka SIXTOVÁ, Luboš PETRUŽELKA and Miloš ŠTÍCHA. Pemetrexed in the second line chemotherapy in non-small cell lung cancer. A multicentre prospective analysis of data from clinical practise. In \textit{Journal of Thoracic Oncology, Volume 6, Supplement 2, Proceedings of the14th World Conference on Lung Cancer}. 2011. ISSN~1556-0864.
|
